Found 0 matching trials
Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer PHASE2 RATIONALE: Preoperative 5-Fu based chemoradiation has become standard treat...
Show More Location
Gastrointestinal Hospital, Sun Yatsen University
Learn More & Join Trial
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer PHASE4 The purpose of this study is to investigate whether preoperative TAC is abl...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer PHASE2 To evaluate the safety and effectiveness of a novel neoadjuvant treatment s...
Show More Location
Henry Ford Health System
Learn More & Join Trial
A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets PHASE2 The population receiving ivosimab combined with chemotherapy for neoadjuvan...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management PHASE2 The study is designed to test the hypothesis that patients with Locally adv...
Show More Status
Active Not Recruiting
Location
University of California, Irvine
Learn More & Join Trial
Outcome of Neoadjuvant Chemotherapy for Obstructive Colon Cancer NA In this study, patients with obstructive colon cancer will be divided into ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma PHASE2 This is a phase II, single arm, non-randomized, open label study of liposom...
Show More Status
Active Not Recruiting
Location
University of Florida
Learn More & Join Trial
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. PHASE2 This study hypothesizes that approximately 50% of rectal cancer patients ca...
Show More Location
Nacional Cancer Institute
Learn More & Join Trial
Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old PHASE3 The primary objective of the NACRE-2 trial is to assess whether the additio...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab PHASE2 Liver is the most common site of metastases from colorectal cancer. Neoadju...
Show More Location
Asan Medical Center
Learn More & Join Trial